<DOC>
	<DOCNO>NCT01638819</DOCNO>
	<brief_summary>Evaluate efficacy one infusion stem cell autologous umbilical cord blood patient autism six month infusion measure change expressive receptive language . Also demonstrate improve behavior , learning , change Serum tumor necrosis factor alpha ( TNF-α ) , tumor necrosis factor beta ( TNF-β ) , interleukin 1-alpha ( IL-1α ) , interleukin 1-beta ( IL-1β ) , interleukin 6 ( IL-6 ) , interleukin 10 ( IL-10 ) , interleukin 13 ( IL-13 ) .</brief_summary>
	<brief_title>Autologous Cord Blood Stem Cells Autism</brief_title>
	<detailed_description>This single-center , randomize , placebo-controlled , crossover outpatient study 15 subject receive one infusion autologous umbilical cord blood ( AUCB ) contain minimum 10 million total nucleated cell per kilogram ( TNC/kg ) 15 subject receive infusion placebo ( saline ) . After 24-week follow-up testing conduct , group crossover patient initially receive AUCB receive placebo patient receive placebo baseline receive cord blood . Both group test 24-weeks infusion . The neuropsychologist , PI , staff Cord Blood Registry ( CBR ) , parent blind infusion sequence . The duration participation study subject approximately 55 week . This include one screening visit period approximately 6 week , one visit baseline testing , one day infusion TNC ( minimum 10 million/kg ) saline placebo follow 24 week follow-up . A second baseline visit conduct week-24 second infusion TNC saline placebo occur 5-7 day . Twenty-four additional week follow-up occur second infusion .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<criteria>Age 2 7 year age Diagnosis Autistic Disorder diagnose Diagnostic Statistical Manual , 4th Edition , Text Revision ( DSMIVTR ) developmental delay , ADOS A sufficient quantity autologous cord blood store Cord Blood Registry store process use Thermogenesis AutoXpress Platform Stable current medication least 2 month prior infusion cord blood Medical record indicate patient genetic condition cerebral palsy , cystic fibrosis , muscular dystrophy , crohns disease , rheumatoid disease , fragile X , Retts Syndrome , Angelman Syndrome , tuberous sclerosis , epilepsy , know genetic defect overlap autism spectrum . Results EEG within 12months baseline English speaking CNS infection Extreme prematurity ( &lt; 34 week gestation ) Severe Cognitive Disability IQ 45 autism Clinical seizure activity within 6 month baseline Lennox Gastaut syndrome infantile spasm Dravet syndrome HIV , renal hepatic impairment Prior hematological malignant disease Fever 101 F within 2 week prior infusion Serious CNS infection trauma Unwilling commit followup Mental illness include schizophrenia Pervasive Developmental Disorder—Not Otherwise Specified Asperger 's Disorder Cord blood unit le 85 % viable , TNC le 10 million/kg , sterility test result positive Garlic allergy Previous adverse reaction Dimethyl Sulfoxide ( DMSO ) Maternal medical record indicate communicable disease include HIV , Hepatitis B C , syphilis , cytomegalovirus ( CMV ) Currently take antiinflammatory medication History asthma may potentially require treatment steroid Inflammatory Disease Renal/hepatic disease : serum Creatinine &gt; 1.5 mg/dl total Bilirubin &gt; 1.5 mg/dl Allergic diphenhydramine ( Benadryl ) Treatment chelation therapy , hyperbaric oxygen therapy , pig worm therapy , alternative therapy investigator deem clinically relevant</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>